Levocetirizine Dihydrochloride Suspension

levocetirizine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Levocetirizine Hcl works by blocking the actions of histamine. Levocetirizine Hcl is used to treat symptoms of perennial allergies in adults and children who are at least 6 months old. Levocetirizine Hcl is also used to treat symptoms of seasonal allergies in adults and children who are at least 2 years old and it is also used to treat itching and swelling caused by chronic urticaria (hives) in adults and children who are at least 6 months old.
Allergic Rhinitis
Levocitrizine is indicated for the relief of symptoms associated with allergic rhinitis (seasonal and perennial) in adults and children 6 years of age and older.
Chronic Idiopathic Urticaria
Levocitrizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older.

PHARMACOKINETIC PROPERTIES OF LEVOCETIRIZINE DIHYDROCHLORIDE

ABSORPTION
Rapidly and extensively absorbed. T max is 0.9 h. C max is 270 and 308 ng/mL after single and repeated once-daily dosing, respectively. Steady state achieved after 2 days.
METABOLISM
Metabolism is less than 14% and by aromatic oxidation, N- and Odealkylation, and taurine conjugation.
DISTRIBUTION
Plasma protein binding about 92%. Vd is approximately 0.4 L/kg.
ELIMINATION
The t ½ is about 8 to 9 h. Elimination is 85.4% and 12.9% via urine and feces, respectively. Excreted both by glomerular filtration and active tubular transport.
Like cetirizine, levocetirizine is to a high degree excreted unchanged: less than 14% of a given dose is converted into metabolites. There are several different metabolic pathways, including through the CYP1A2, 2C9, 2C19, 2D6, 2E1 and 3A4t pathways in the liver. A total of 13 different metabolites have been observed. In vitro studies have shown that levocetirizine does not affect the CYP isoenzymes of the liver, and the risk of interactions in connection with metabolism is considered to be very low.
There is a risk of interaction if the drug is used concurrently with alcohol or other CNS depressants.
The most commonly reported adverse effects are:
  • Sleepiness
  • Dizziness
  • Dry Mouth
Store in a well closed container in cool, dry place, away from direct heat and light.